CHC Healthcare Group (4164) - Cash Flow Conversion Efficiency
Based on the latest financial reports, CHC Healthcare Group (4164) has a cash flow conversion efficiency ratio of 0.034x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$273.30 Million ≈ $8.61 Million USD) by net assets (NT$7.98 Billion ≈ $251.38 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
CHC Healthcare Group - Cash Flow Conversion Efficiency Trend (2009–2024)
This chart illustrates how CHC Healthcare Group's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 4164 current and long-term liabilities for a breakdown of total debt and financial obligations.
CHC Healthcare Group Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of CHC Healthcare Group ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Dynamix Corporation
NASDAQ:ETHM
|
-0.003x |
|
Vina San Pedro
SN:VSPT
|
0.001x |
|
Parrot
PA:PARRO
|
-0.462x |
|
Franklin Covey Company
NYSE:FC
|
0.002x |
|
NOVAREX Co.Ltd
KQ:194700
|
0.101x |
|
FineTek Co Ltd
TWO:4549
|
0.008x |
|
Wei Chih Steel Industrial Co Ltd
TW:2028
|
0.114x |
|
TIDEWATER RENEWABLES LTD
F:7GZ
|
-0.003x |
Annual Cash Flow Conversion Efficiency for CHC Healthcare Group (2009–2024)
The table below shows the annual cash flow conversion efficiency of CHC Healthcare Group from 2009 to 2024. For the full company profile with market capitalisation and key ratios, see 4164 market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | NT$6.70 Billion ≈ $211.24 Million |
NT$99.37 Million ≈ $3.13 Million |
0.015x | -89.57% |
| 2023-12-31 | NT$6.78 Billion ≈ $213.47 Million |
NT$962.59 Million ≈ $30.33 Million |
0.142x | +38.53% |
| 2022-12-31 | NT$6.40 Billion ≈ $201.73 Million |
NT$656.66 Million ≈ $20.69 Million |
0.103x | -6.54% |
| 2021-12-31 | NT$6.31 Billion ≈ $198.92 Million |
NT$692.79 Million ≈ $21.83 Million |
0.110x | -28.08% |
| 2020-12-31 | NT$6.00 Billion ≈ $189.03 Million |
NT$915.47 Million ≈ $28.84 Million |
0.153x | -31.81% |
| 2019-12-31 | NT$5.32 Billion ≈ $167.53 Million |
NT$1.19 Billion ≈ $37.48 Million |
0.224x | +193.99% |
| 2018-12-31 | NT$5.13 Billion ≈ $161.73 Million |
NT$390.69 Million ≈ $12.31 Million |
0.076x | +27.30% |
| 2017-12-31 | NT$4.91 Billion ≈ $154.83 Million |
NT$293.82 Million ≈ $9.26 Million |
0.060x | -73.87% |
| 2016-12-31 | NT$4.97 Billion ≈ $156.57 Million |
NT$1.14 Billion ≈ $35.83 Million |
0.229x | +152.27% |
| 2015-12-31 | NT$5.57 Billion ≈ $175.37 Million |
NT$504.90 Million ≈ $15.91 Million |
0.091x | -32.92% |
| 2014-12-31 | NT$4.69 Billion ≈ $147.78 Million |
NT$634.23 Million ≈ $19.98 Million |
0.135x | -27.47% |
| 2013-12-31 | NT$4.66 Billion ≈ $146.91 Million |
NT$869.31 Million ≈ $27.39 Million |
0.186x | +141.53% |
| 2012-12-31 | NT$3.83 Billion ≈ $120.80 Million |
NT$295.94 Million ≈ $9.32 Million |
0.077x | -53.16% |
| 2011-12-31 | NT$2.90 Billion ≈ $91.23 Million |
NT$477.21 Million ≈ $15.03 Million |
0.165x | -32.11% |
| 2010-12-31 | NT$2.10 Billion ≈ $66.21 Million |
NT$510.14 Million ≈ $16.07 Million |
0.243x | +415.73% |
| 2009-12-31 | NT$805.32 Million ≈ $25.37 Million |
NT$-61.92 Million ≈ $-1.95 Million |
-0.077x | -- |
About CHC Healthcare Group
CHC Healthcare Group, together with its subsidiaries, trades in medical equipment, pharmaceutical products, and health food in Taiwan, China, and internationally. The company is also involved in the leasing, installing, servicing, and repairing of medical instruments for use in various specialties, such as radiation oncology, medical imaging, neurology, surgery, ophthalmology, robot rehabilitatio… Read more